Lake Street Advisors Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.74M Buy
18,852
+1,078
+6% +$97.1K 0.08% 158
2024
Q3
$1.49M Buy
17,774
+473
+3% +$36.1K 0.07% 163
2024
Q2
$1.19M Sell
17,301
-743
-4% -$49.6K 0.06% 189
2024
Q1
$1.32M Sell
18,044
-267
-1% -$20.5K 0.06% 185
2023
Q4
$1.48M Buy
18,311
+1,129
+7% +$87.9K 0.07% 173
2023
Q3
$1.29M Sell
17,182
-234
-1% -$18K 0.08% 147
2023
Q2
$1.34M Buy
17,416
+368
+2% +$29.4K 0.07% 153
2023
Q1
$1.42M Buy
17,048
+3,744
+28% +$310K 0.09% 141
2022
Q4
$1.14M Sell
13,304
-362
-3% -$28.7K 0.08% 141
2022
Q3
$843K Buy
13,666
+1,163
+9% +$73.3K 0.06% 159
2022
Q2
$773K Sell
12,503
-260
-2% -$16.1K 0.06% 156
2022
Q1
$759K Sell
12,763
-417
-3% -$26.7K 0.05% 160
2021
Q4
$957K Buy
13,180
+425
+3% +$29.3K 0.06% 147
2021
Q3
$891K Buy
12,755
+1,260
+11% +$88.5K 0.1% 112
2021
Q2
$815K Buy
11,495
+338
+3% +$22.6K 0.06% 125
2021
Q1
$721K Sell
11,157
-3,068
-22% -$198K 0.06% 124
2020
Q4
$829K Sell
14,225
-14,173
-50% -$855K 0.07% 114
2020
Q3
$1.79M Sell
28,398
-3,878
-12% -$269K 0.17% 61
2020
Q2
$2.48M Buy
32,276
+5,310
+20% +$407K 0.25% 48
2020
Q1
$2.02M Buy
26,966
+16,214
+151% +$1.12M 0.25% 48
2019
Q4
$699K Buy
10,752
+1,440
+15% +$93.8K 0.07% 93
2019
Q3
$432K Sell
9,312
-2
-0% -$131 0.05% 109
2019
Q2
$629K Buy
9,314
+568
+6% +$37.4K 0.07% 85
2019
Q1
$569K Buy
8,746
+902
+11% +$60K 0.06% 95
2018
Q4
$491K Sell
7,844
-1,035
-12% -$72.3K 0.06% 94
2018
Q3
$686K Sell
8,879
-3,092
-26% -$234K 0.08% 67
2018
Q2
$848K Sell
11,971
-442
-4% -$31.2K 0.08% 95
2018
Q1
$936K Buy
12,413
+221
+2% +$17.6K 0.11% 70
2017
Q4
$873K Buy
+12,192
New +$926K 0.1% 81

Other funds holding GILD

Lake Street Advisors Group's GILD Position: Q4 2024 in Review

Lake Street Advisors Group increased its Gilead Sciences (GILD) stake by 6.1% in Q4 2024, buying an estimated $97.1K and bringing the position to 18,852 shares worth $1.74M. The position accounts for 0.08% of the portfolio, ranked #158.

Lake Street Advisors Group first reported a position in GILD in Q4 2017 and has held it in 29 quarters since. The position peaked at $2.48M in Q2 2020. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Lake Street Advisors Group held 18,852 shares of Gilead Sciences worth $1.74M as of Q4 2024.
  • Lake Street Advisors Group bought 1,078 Gilead Sciences shares in Q4 2024, an estimated $97.1K.
  • Gilead Sciences made up 0.08% of Lake Street Advisors Group's portfolio in Q4 2024, its #158 holding.
  • Lake Street Advisors Group first reported a position in Gilead Sciences in Q4 2017 and has held it in 29 quarters since.
  • Lake Street Advisors Group's Gilead Sciences position peaked at $2.48M in Q2 2020.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.